Genetic characterization of respiratory syncytial virus highlights a new BA genotype and emergence of the ON1 genotype in Lyon, France, between 2010 and 2014

Human respiratory syncytial virus (RSV) is one of the main causes of severe respiratory tract infections (RTI) and death in children [1]. Almost all children before two years of age have been infected by RSV and multiple reinfections may occur throughout their lifetime [2]. This virus is also reported in adult patients, especially after 65 years old [3,4]. During an acute RSV infection, very few therapeutics are available: there are no specific antiviral treatment and ribavirin is the only antiviral approved for RSV treatment but hardly used due to important side effects.
Source: Journal of Clinical Virology - Category: Virology Authors: Source Type: research